FiveT Fintech

LimeWire is a digital collectibles marketplace focused on the music, art, and entertainment industries. The platform has been relaunched to transform the way fans and artists interact, providing a framework for direct fan membership that helps artists generate a recurring revenue stream. LimeWire enables users to explore, collect, and trade unique digital collectibles, including NFTs, while keeping them informed with timely announcements within the art and entertainment space. Fans gain access to exclusive content and a private community, allowing them to connect directly with their favorite artists and participate actively in their journeys.

Tenity is a global innovation ecosystem and early-stage investor based in Zurich, Switzerland, founded in 2015. The firm operates as an accelerator and incubator, concentrating on companies within the technology sectors. With a mission to shape the future of finance and beyond, Tenity supports startups by providing resources, mentorship, and investment to foster innovation and growth in the evolving technological landscape.

ZELF is a neobank fintech company dedicated to providing accessible financial services to younger generations. Operating in both the EU and the US, ZELF integrates banking functionalities into popular social messaging platforms such as WhatsApp, Facebook Messenger, Discord, Telegram, and Viber. The company aims to simplify monetary transactions by offering features such as AI-powered voice control, invoice creation, and tracking of unpaid invoices, allowing users to manage their finances effortlessly. In June 2022, ZELF introduced its "Bank of the Metaverse" campaign, which combines game assets, NFTs, and fiat currency under a single banking platform, further enhancing its appeal to a tech-savvy audience.

PreComb is a biotechnology company focused on enhancing cancer therapy by developing innovative technologies that tailor treatments to individual patients, particularly for challenging cancers. The company specializes in automated microtumor-based profiling, which allows clinical institutions to conduct in vitro cancer diagnostics directly at the hospital. This technology enables the functional evaluation of various cancer drugs, combinations, and concentrations on patient-derived micro-tumors, thereby optimizing treatment outcomes. By improving the precision of cancer management, PreComb aims to increase success rates in therapies and ultimately enhance the quality of life for patients battling cancer.